Genius Sports Limited
NYSE:GENIInternet Content & Information
-$0.05 today
- Market cap
- $1.64B
- Beta
- 1.92
- P/E (TTM)
- -10.4
- EPS (TTM)
- -$0.59
Volume 7.36M
Average 6.05M
GENI Accounts Receivables
Cash effect of the change in amounts owed by customers; growing receivables consume cash.
Genius Sports LimitedNYSE: GENI
Accounts Receivables · Q1 FY2026 · quarter ended Mar 2026
Accounts receivables growth accelerates
Q1 FY2026 accounts receivables of $25.29M rose 807.4% year over year, ahead of the -467.1% change in trailing-twelve-month accounts receivables. Over 3 fiscal years it compounded at +88.0% a year.
Context
- Accounts receivables amounted to 10.6% of revenue in FY2025, up 9.1 pp from a year earlier.
- Accounts receivables grew in size in 2 of the last 3 fiscal years.
- FY2025 was the largest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +807.4% holds above the trailing-twelve-month pace of -467.1%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Receivables history
USD · from the cash flow
- Latest · FY2025
- (71.02M) USD
- Year-over-year change
- -823.6%
| Period | Period end | Accounts Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (71.02M) | -823.6% |
| FY2024 | 2024-12-31 | (7.69M) | +75.1% |
| FY2023 | 2023-12-31 | (30.88M) | -188.7% |
| FY2022 | 2022-12-31 | (10.7M) | +71.6% |
| FY2021 | 2021-12-31 | (37.68M) | — |
Accounts Receivables vs competitors
How GENI compares with its peers on the latest reported figures
- Peers report in different currencies, so accounts receivables is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -467.1% is the lowest of 7, against a peer median of +100.1%.
- Accounts receivables amounts to 6.8% of revenue for GENI, versus a peer median of 0.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $48.52M USD | -467.1% | +88.0% | 6.8% | |
KYIVKyivstar Group Ltd. Common Shares | LTM Jun 2026 | $47M USD | — | — | 3.7% |
| LTM Mar 2026 | $35.89M USD | -30.8% | -5.5% | 2.4% | |
| LTM Jun 2026 | £30.94M GBP | +147.5% | +7.2% | 4.6% | |
| LTM Jun 2026 | $1.99M USD | -107.5% | — | 0.1% | |
| LTM Jun 2026 | $128K USD | +1063.6% | — | 3.2% | |
| LTM Jun 2026 | $5.3K USD | +100.2% | -23.5% | 0.1% | |
| LTM Jun 2026 | $0 USD | — | — | 0.0% | |
| LTM Jun 2026 | $0 USD | — | +28.1% | 0.0% | |
| LTM Jun 2025 | $0 USD | +100.0% | — | 0.0% | |
| LTM Jun 2025 | CN¥0 CNY | — | — | 0.0% | |
| Peer median (excluding GENI) | — | +100.1% | +0.9% | 0.1% | |
Competitors are the stored peer set for GENI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (592.75M) | (181.64M) | (85.53M) | (63.04M) | (111.58M) |
| Depreciation & Amortization | 59.35M | 68.53M | 77.31M | 72.57M | 70.52M |
| Deferred Income Tax | (13.41M) | (113K) | (444K) | (2.72M) | (7.07M) |
| Stock-Based Compensation | 489.47M | 89.84M | 35.32M | 54.48M | 148.54M |
| Change in Working Capital | (41.74M) | 18.79M | (25.1M) | 10.71M | 15.5M |
| Accounts Receivables | (37.68M) | (10.7M) | (30.88M) | (7.69M) | (71.02M) |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 9.58M | 15.74M | 22.07M | (20.72M) | 75.59M |
| Other Working Capital | (13.64M) | 13.74M | (16.28M) | 39.12M | 10.94M |
| Other Non-Cash Items | 35.77M | 1.14M | 13.32M | 9.87M | (29.52M) |
| Operating Cash Flow | (63.31M) | (3.46M) | 14.88M | 81.86M | 86.4M |
| Capital Expenditures | (33.36M) | (47.55M) | (49.14M) | (64.26M) | (21.85M) |
| Acquisitions (Net) | (103.87M) | (20K) | 0 | 0 | (14.8M) |
| Purchases of Investments | 0 | (150K) | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 2.79M |
| Other Investing Activities | (22.03M) | (48.68M) | (44M) | (51.29M) | 0 |
| Investing Cash Flow | (132.32M) | (54.82M) | (47.57M) | (62.69M) | (92.91M) |
| Debt Repayment | (96.96M) | (21K) | (7.41M) | (7.6M) | (21K) |
| Common Stock Issued | 571.58M | 0 | 0 | 0 | 144M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | (313.16M) | 0 | 0 | 0 | 0 |
| Other Financing Activities | 248.91M | 0 | 6.81M | 0 | 0 |
| Financing Cash Flow | 410.36M | (21K) | (596K) | (7.6M) | 143.98M |
| Effect of Forex Changes | (4.14M) | (5.06M) | 63K | (2.13M) | 7.85M |
| Net Change in Cash | 210.6M | (63.36M) | (33.23M) | 9.45M | 145.32M |
| Free Cash Flow | (96.67M) | (51.01M) | (34.27M) | 17.61M | 64.54M |
Genius Sports Limited
NYSE:GENI
Intrinsic Alpha fair value
Locked
Current Price
$6.11
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.